Kashmik Formulation Profile
Key Indicators
- Authorised Capital ₹ 9.00 Cr
as on 27-06-2024
- Paid Up Capital ₹ 8.78 Cr
as on 27-06-2024
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.20 Cr
as on 27-06-2024
- Revenue 245.16%
(FY 2022)
- Profit 77.54%
(FY 2022)
- Ebitda 266.72%
(FY 2022)
- Net Worth -3.44%
(FY 2022)
- Total Assets 161.39%
(FY 2022)
About Kashmik Formulation
The Corporate was formerly known as Nectarlife Care Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 Cr and a paid-up capital of Rs 8.78 Cr.
The company currently has active open charges totaling ₹19.20 Cr.
Nileshkumar Patel and Mahadevbhai Patel serve as directors at the Company.
- CIN/LLPIN
U24239GJ2017PTC095077
- Company No.
095077
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Kashmik Formulation Private Limited offer?
Kashmik Formulation Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antiparasitic Drug.
Who are the key members and board of directors at Kashmik Formulation?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nileshkumar Patel  | Director | 11-Jan-2017 | Current |
| Mahadevbhai Patel | Director | 11-Jan-2017 | Current |
Financial Performance of Kashmik Formulation.
Kashmik Formulation Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 245.16% increase. The company also saw a substantial improvement in profitability, with a 77.54% increase in profit. The company's net worth dipped by a decrease of 3.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kashmik Formulation?
In 2023, Kashmik Formulation had a promoter holding of 55.94% and a public holding of 44.06%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Nectar Infrabuild Private LimitedActive 2 years 2 months
Nileshkumar Patel and Mahadevbhai Patel are mutual person
- Dhvija Investment Private LimitedActive 1 year 3 months
Nileshkumar Patel and Mahadevbhai Patel are mutual person
- Neerjani Fintech Private LimitedActive 1 year 29 days
Nileshkumar Patel and Mahadevbhai Patel are mutual person
- Nectar Human Resource Services Private LimitedActive 2 years 2 months
Nileshkumar Patel is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 24 Feb 2023 | ₹8.40 Cr | Open |
State Bank Of India Creation Date: 16 Jun 2022 | ₹2.00 M | Open |
State Bank Of India Creation Date: 26 Feb 2021 | ₹10.60 Cr | Open |
How Many Employees Work at Kashmik Formulation?
Kashmik Formulation has a workforce of 29 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kashmik Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kashmik Formulation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
